Market closed

ProKidney Corp./$PROK

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Ticker

$PROK
Trading on

Industry

Biotechnology

Employees

204

ProKidney Corp. Metrics

BasicAdvanced
$78M
-
-$0.62
1.48
-
$78M
1.48
$1.34
$0.55
10.931
9.96
0.615
0.806
-19,816.89%
-25.87%
-41.20%
772.294
-0.08
-0.08
-0.376
8.73%
19.53%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PROK

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for ProKidney Corp. stock?

ProKidney Corp. (PROK) has a market cap of $78M as of April 06, 2025.

What is the P/E ratio for ProKidney Corp. stock?

The price to earnings (P/E) ratio for ProKidney Corp. (PROK) stock is 0 as of April 06, 2025.

Does ProKidney Corp. stock pay dividends?

No, ProKidney Corp. (PROK) stock does not pay dividends to its shareholders as of April 06, 2025.

When is the next ProKidney Corp. dividend payment date?

ProKidney Corp. (PROK) stock does not pay dividends to its shareholders.

What is the beta indicator for ProKidney Corp.?

ProKidney Corp. (PROK) has a beta rating of 1.48. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.